AIM To study the role of cannabis use in the onset of symptoms and disorders in the schizophrenia spectrum. DESIGN Review of five population-based, longitudinal studies on the relationship between cannabis use and problems ranging from the experience of psychotic symptoms to hospitalization with a confirmed diagnosis of schizophrenia. Several hypotheses are examined that may explain this rela...

OBJECTIVE Psychiatric hospitalization of patients imposes heavy burdens on caregivers, but little is known about this issue in Iran. The present cross-sectional study aimed to investigate the risk factors associated with psychiatric hospitalization of patients with schizophrenia who were the regular clients for the educational programs of The Iranian Society for Supporting Individuals with Schi...

Patients with schizophrenia, especially during period of their hospitalization, are likely to constitute a high-risk group of individuals with respect to prevalence of oral diseases. Several factors are mentioned in the manuscript that may contribute to the finding of increased prevalence of oral diseases in patients with schizophrenia. Unfortunately, some of these can be attributed to dental p...

Introduction Several factors related to the risk of requiring psychiatric hospitalization have been described in patients diagnosed with schizophrenia treated methods other than home treatment. With regard symptoms, high global illness severity and positive symptoms most frequently schizophrenia. However, there are no studies describing which clinical increase likelihood being hospitalized whil...

BACKGROUND Serious mental illnesses are associated with increased risk of cardiometabolic comorbidities. The objective of this study was to evaluate the prevalence of cardiometabolic comorbidity and its association with hospitalization outcomes and costs among inpatients with schizophrenia or bipolar disorder. METHODS This retrospective database analysis reviewed patients with an inpatient di...

BACKGROUND Long-acting injectable risperidone, a second-generation antipsychotic agent, may improve adherence to treatment and outcomes in schizophrenia, but it has not been tested in a long-term randomized trial involving patients with unstable disease. METHODS We randomly assigned patients in the Veterans Affairs (VA) system who had schizophrenia or schizoaffective disorder and who had been...

schizophrenia is one of the most severe psychiatric disorders and 25% of the patients need long term hospitalization. they have somatic illness that may be ignored and lead to death. considering the lack of information regarding the causes of death in schizophrenic patients, the aim of this study was to determine the main causes of death in the long term hospitalized schizophrenic patients in s...

Throughout history, given the lack of understanding of schizophrenia and lack of effective treatment options, patients were often committed to asylums and later psychiatric institutions, often for prolonged periods of time. First antipsychotic medications helped to bring about changes in approach to these patients and facilitated deinstitutionalization, and discovery of new drugs with differing...

Aripiprazole has been reported to exert variable effects on cognitive function in patients with schizophrenia. Therefore, in the present study, we evaluated biological markers, clinical data, and psychiatric symptoms in order to identify factors that influence cognitive function in patients with schizophrenia undergoing aripiprazole treatment. We evaluated cognitive function in 51 patients with...

OBJECTIVE The prevalence of cigarette smoking among schizophrenia patients is significantly higher than in the general population; this may reflect self-medication of symptoms and/or adverse effects of neuroleptics. The authors examined the prevalence of cigarette smoking in apparently healthy adolescents later hospitalized for schizophrenia. METHOD Each year, a random sample of male Israeli ...